Interactions between kidney disease and diabetes: dangerous liaisons (Q26740630)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27471550%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

review article

1 reference

title

Interactions between kidney disease and diabetes: dangerous liaisons (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27471550%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

Carolina C R Betônico

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27471550%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Sergio Vencio

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27471550%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

Roberto Pecoits-Filho

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27471550%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Hugo Abensur

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27471550%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Alisson Diego Machado

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27471550%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Erika B Parente

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27471550%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Márcia Queiroz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27471550%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

João Eduardo Nunes Salles

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27471550%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Silvia Titan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27471550%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

language of work or name

English

0 references

publication date

28 July 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27471550%20AND%20SRC:MED&resulttype=core&format=json

Diabetology and Metabolic Syndrome

20 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27471550%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27471550%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

1

0 references

page(s)

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27471550%20AND%20SRC:MED&resulttype=core&format=json

Standards of medical care in diabetes--2012

20 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Use of metformin in the setting of mild-to-moderate renal insufficiency

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Updates on the management of diabetes in dialysis patients

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

SGLT-2 receptor inhibitors for treating patients with type 2 diabetes mellitus: a systematic review and network meta-analysis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Standards of medical care in diabetes--2014

7 April 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Impaired fasting glucose and impaired glucose tolerance: implications for care

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

cAMP-GEFII is a direct target of cAMP in regulated exocytosis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Insulin degradation: mechanisms, products, and significance

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Diabetes Care: “state of the union”

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Effects of intensive glucose lowering in type 2 diabetes

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Central nervous system control of food intake

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Glucose control and vascular complications in veterans with type 2 diabetes

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Cellular mechanisms of insulin resistance

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Haemodialysis-induced hypoglycaemia and glycaemic disarrays

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

A comprehensive review of urologic complications in patients with diabetes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Glycemic management in ESRD and earlier stages of CKD.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Insulin degludec: pharmacokinetics in patients with renal impairment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Diabetic nephropathy: diagnosis and treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Insulin requirements in patients with diabetes and declining kidney function: differences between insulin analogues and human insulin?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Glycated hemoglobin and risk of death in diabetic patients treated with hemodialysis: a meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Review of insulin-dependent and insulin-independent agents for treating patients with type 2 diabetes mellitus and potential role for sodium-glucose co-transporter 2 inhibitors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Diabetic retinopathy and microalbuminuria can predict macroalbuminuria and renal function decline in Japanese type 2 diabetic patients: Japan Diabetes Complications Study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Measurement of Hba(1C) in patients with chronic renal failure

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Diabetes management in the kidney patient

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Haemoglobin A1c: Historical overview and current concepts

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Hemoglobin A(1c) levels and mortality in the diabetic hemodialysis population: findings from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

A randomized trial of two weight-based doses of insulin glargine and glulisine in hospitalized subjects with type 2 diabetes and renal insufficiency

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Glycemic control and cardiovascular mortality in hemodialysis patients with diabetes: a 6-year cohort study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

The effect of glucagon-like peptide 1 on cardiovascular risk

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Rapid improvement of glycemic control in type 2 diabetes using weekly intensive multifactorial interventions: structured glucose monitoring, patient education, and adjustment of therapy-a randomized controlled trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Glucose handling by the kidney

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Review of hemoglobin A1c in the management of diabetes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Serum fructosamine versus glycosylated hemoglobin as an index of glycemic control, hospitalization, and infection in diabetic hemodialysis patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Management of the diabetic patient with advanced chronic kidney disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Effects of intensive blood-pressure control in type 2 diabetes mellitus

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Frequency of hypoglycemia and its significance in chronic kidney disease.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Rosiglitazone is associated with mortality in chronic hemodialysis patients.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

1,5-anhydroglucitol monitoring in diabetes: a mass balance perspective

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Insulin therapy in renal disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Interactions between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implications.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Insulin detemir: a long-acting insulin product

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Central insulin action in energy and glucose homeostasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Pharmacokinetics of insulin aspart in obesity, renal impairment, or hepatic impairment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Enhancing Incretin Action for the Treatment of Type 2 Diabetes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Diabetic autonomic neuropathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Role of the kidney in hyperglycemia in type 2 diabetes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

The national glycohemoglobin standardization program: a five-year progress report.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Management of drugs affecting blood glucose in diabetic patients with renal failure.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Serum 1,5-anhydroglucitol (1,5 AG): new clinical marker for glycemic control

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Uptake and release of glucose by the human kidney. Postabsorptive rates and responses to epinephrine

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Insulin metabolism and degradation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Insulin resistance in uremia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Hydrolysis and transport of small peptides by the proximal tubule

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

The renal metabolism of insulin

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

28 September 2017

Renal gluconeogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Renal substrate metabolism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Glucose homeostasis and the kidney

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Glucose clamp technique: a method for quantifying insulin secretion and resistance

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

A critical evaluation of glycated protein parameters in advanced nephropathy: a matter of life or death: time to dispense with the hemoglobin A1C in end-stage kidney disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Role of the Kidney in the Metabolism of Fructose in 60-hour Fasted Humans

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Obesity and insulin resistance in humans: a dose-response study.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Glucose and insulin metabolism in uremia.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp

31 May 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Short-term variability in measures of glycemia and implications for the classification of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Hemoglobin A(1c) and fructosamine for assessing glycemic control in diabetic patients with CKD stages 3 and 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Target for glycemic control in type 2 diabetic patients on hemodialysis: effects of anemia and erythropoietin injection on hemoglobin A(1c).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Beverage intake, diabetes, and glucose control of adults in America

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Influence of age and nutritional status on glycated albumin values in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Regression of microalbuminuria in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Diabetic management in patients with renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Hypoglycemia in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Combined angiotensin inhibition for the treatment of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic patients: the Renin-Angiotensin System Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Long-term glycemic control measurements in diabetic patients receiving hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Polyunsaturated fatty acid consumption may play a role in the onset and regression of microalbuminuria in well-controlled type 1 and type 2 diabetic people: a 7-year, prospective, population-based, observational multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

A low-sodium diet potentiates the effects of losartan in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Characteristics and time course of severe glimepiride- versus glibenclamide-induced hypoglycaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Safety and efficacy of repaglinide in type 2 diabetic patients with and without impaired renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Hepatotoxicity associated with acarbose therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Severe acute renal failure in patients treated with glucagon-like peptide-1 receptor agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Insulin resistance and postprandial triglyceride levels in primary renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Renal and metabolic effects of insulin lispro in type 2 diabetic subjects with overt nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Management of glycemia in patients with diabetes mellitus and CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Comparison of Pharmacokinetics and Dynamics of the Long-Acting Insulin Analogs Glargine and Detemir at Steady State in Type 1 Diabetes: A double-blind, randomized, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Interactive effect of retinopathy and macroalbuminuria on all-cause mortality, cardiovascular and renal end points in Chinese patients with Type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

State of the art in trueness and interlaboratory harmonization for 10 analytes in general clinical chemistry

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Metformin-associated lactic acidosis in patients with renal impairment solely due to drug accumulation?

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Pharmacokinetics and pharmacodynamics of lispro-insulin in hemodialysis patients with diabetes mellitus.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4964290

Substrate-utilization of the Human Kidney

28 November 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Gluconeogenesis by the Human Kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study

21 January 2018

1 reference

12 December 2020

Insulin regulation of renal glucose metabolism in humans

1 reference

12 December 2020

Insulin analogue usage in a haemodialysis patient with type 2 diabetes mellitus

1 reference

12 December 2020

Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: a prospective 24-week randomized placebo-controlled trial

1 reference

12 December 2020

Cardiac autonomic neuropathy predicts renal function decline in patients with type 2 diabetes: a cohort study

1 reference

12 December 2020

[Consensus document on treatment of type 2 diabetes in patients with chronic kidney disease]

1 reference

12 December 2020

Advantage of insulin glulisine over regular insulin in patients with type 2 diabetes and severe renal insufficiency

1 reference

12 December 2020

Saxagliptin improves glycaemic control and is well tolerated in patients with type 2 diabetes mellitus and renal impairment

1 reference

12 December 2020

Can glycohemoglobin be used to assess glycemic control in patients with chronic renal failure?

1 reference

12 December 2020

Serum albumin: a predictor of long-term outcome in peritoneal dialysis patients

1 reference

12 December 2020

[Autonomic neuropathy: a high risk complication for type 1 diabetes mellitus]

1 reference

12 December 2020

[Metabolism of the human kidney.]

1 reference

12 December 2020

Variability in the relationship between mean plasma glucose and HbA1c: implications for the assessment of glycemic control

1 reference

12 December 2020

The natural history of diabetic autonomic neuropathy

1 reference

12 December 2020

Effects of glucagon on renal and hepatic glutamine gluconeogenesis in normal postabsorptive humans

1 reference

12 December 2020

Metformin: the safest hypoglycaemic agent in chronic kidney disease?

1 reference

12 December 2020

Sexual dysfunction in the male patient with uremia: A reappraisal

1 reference

12 December 2020

Consensus statement on the worldwide standardisation of the HbA1c measurement

1 reference

12 December 2020

Severe hypoglycemia in type I diabetic patients with impaired kidney function

1 reference

12 December 2020

Effects of physiological hyperinsulinemia on systemic, renal, and hepatic substrate metabolism

1 reference

12 December 2020

Comments on 'KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease'

1 reference

12 December 2020

Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin(*)

1 reference

12 December 2020

https://api.crossref.org/works/10.1186%2FS13098-016-0159-Z

1 reference

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1186/S13098-016-0159-Z

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27471550%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

20 March 2020

1017298452

0 references

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27471550%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

PubMed publication ID

27471550

2 references